Lista de obras - Laura Ambra Nicolini - Dominio Público Uruguay

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation

artículo científico publicado en 2015

CD8(+)CD28(-)CD127(lo)CD39(+) regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?

artículo científico publicado en 2017

Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy

artículo científico publicado en 2020

Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?

artículo científico publicado en 2017

Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells

artículo científico publicado en 2017

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis

artículo científico publicado en 2017

Drug treatment for multidrug-resistant Acinetobacter baumannii infections.

artículo científico publicado en 2008

Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?

artículo científico publicado en 2015

Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status.

artículo científico publicado en 2014

Evaluation of insulin resistance in a cohort of HIV-infected youth

artículo científico publicado en 2007

Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients

artículo científico publicado en 2015

HCV treatment in children and young adults with HIV/HCV co-infection in Europe

artículo científico publicado en 2015

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.

artículo científico publicado en 2014

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

artículo científico publicado en 2014

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

artículo científico publicado en 2017

Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.

artículo científico publicado en 2009

Insights on common vaccinations in HIV-infection: efficacy and safety

artículo científico publicado en 2015

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort

artículo científico publicado en 2014

Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermidis endocarditis and spondylodiscitis.

artículo científico publicado en 2009

Modulation of the Natural Killer Cell Compartment during DAAs treatment in Interferon-naïve HCV patients: The type of DAA matters

scientific article published on 23 August 2018

Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adults.

artículo científico publicado en 2011

Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women?

artículo científico publicado en 2013

Role of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and treatment of sarcoidosis in an HIV-2-infected patient

artículo científico publicado en 2015

The role of telavancin in the treatment of MRSA infections in hospital

Therapeutic management of chronic hepatitis B in clinical practice: a region-wide survey.

artículo científico publicado en 2015

Tigecycline use in serious nosocomial infections: a drug use evaluation.

artículo científico publicado en 2010

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia

scientific article published on 20 August 2020

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients

artículo científico publicado en 2018

Lista de obras de Laura Ambra Nicolini

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation

CD8(+)CD28(-)CD127(lo)CD39(+) regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?

Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy

Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?

Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis

Drug treatment for multidrug-resistant Acinetobacter baumannii infections.

Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?

Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status.

Evaluation of insulin resistance in a cohort of HIV-infected youth

Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients

HCV treatment in children and young adults with HIV/HCV co-infection in Europe

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.

Insights on common vaccinations in HIV-infection: efficacy and safety

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort

Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermidis endocarditis and spondylodiscitis.

Modulation of the Natural Killer Cell Compartment during DAAs treatment in Interferon-naïve HCV patients: The type of DAA matters

Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adults.

Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women?

Role of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and treatment of sarcoidosis in an HIV-2-infected patient

The role of telavancin in the treatment of MRSA infections in hospital

Therapeutic management of chronic hepatitis B in clinical practice: a region-wide survey.

Tigecycline use in serious nosocomial infections: a drug use evaluation.

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients